These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Chemotherapy for lung cancer: the state of the art in 2009. Higgins MJ; Ettinger DS Expert Rev Anticancer Ther; 2009 Oct; 9(10):1365-78. PubMed ID: 19827996 [TBL] [Abstract][Full Text] [Related]
23. Drug-induced pulmonary toxicity in breast cancer patients treated with systemic therapy: a systematic literature review. Chen S; Ren Y; Dai H; Li Y; Lan B; Ma F Expert Rev Anticancer Ther; 2021 Dec; 21(12):1399-1410. PubMed ID: 34672214 [TBL] [Abstract][Full Text] [Related]
28. [Molecular-targeted drug for non-small cell lung cancer]. Okamoto I Nihon Rinsho; 2012 Nov; 70 Suppl 8():438-42. PubMed ID: 23513880 [No Abstract] [Full Text] [Related]
29. CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity. Torrisi JM; Schwartz LH; Gollub MJ; Ginsberg MS; Bosl GJ; Hricak H Radiology; 2011 Jan; 258(1):41-56. PubMed ID: 21183492 [TBL] [Abstract][Full Text] [Related]
30. Chemotherapy for obstructive atelectasis in nonsmall cell lung cancer: Is this a treatment option? Naronha V; Pinninti R; Joshi A; Prabhash K Indian J Cancer; 2015; 52(3):368-9. PubMed ID: 26905141 [No Abstract] [Full Text] [Related]
31. Pulmonary toxicities from targeted therapies: a review. Barber NA; Ganti AK Target Oncol; 2011 Dec; 6(4):235-43. PubMed ID: 22076388 [TBL] [Abstract][Full Text] [Related]
32. A review of the pulmonary toxicity of cancer chemotherapeutic agents. Weiss RB; Trush DM Oncol Nurs Forum; 1982; 9(1):16-21. PubMed ID: 6916364 [No Abstract] [Full Text] [Related]
33. Targeted therapies development in the treatment of advanced nonsmall cell lung cancer. Gridelli C; Felip E J Biomed Biotechnol; 2011; 2011():415641. PubMed ID: 22219656 [No Abstract] [Full Text] [Related]
35. Pulmonary toxicities of molecular targeted antineoplastic agents: a single-center 10-year experience. Lee MY; Yoon SY; Kim KH; Lee N; Kim HY; Hwang JH; Won JH Korean J Intern Med; 2021 May; 36(3):689-698. PubMed ID: 33412778 [TBL] [Abstract][Full Text] [Related]
37. Systemic Therapy in Nonsmall Cell Lung Cancer and the Role of Biomarkers in Selection of Treatment. Lo B; Laurie SA Thorac Surg Clin; 2021 Nov; 31(4):399-406. PubMed ID: 34696852 [TBL] [Abstract][Full Text] [Related]
38. [Drugs and iatrogenically induced pulmonary toxicity]. Mihălţan F Pneumoftiziologia; 1991; 40(1):15-23. PubMed ID: 1823192 [No Abstract] [Full Text] [Related]
39. Drug-induced pulmonary disease. Part III. Agents used to treat neoplasms or alter the immune system including a brief review of radiation therapy. Demeter SL; Ahamd M; Tomashefski JF Cleve Clin Q; 1979; 46(3):113-24. PubMed ID: 509715 [No Abstract] [Full Text] [Related]